Norges Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,373,360
Closed -$3.76M 2202
2017
Q4
$3.76M Buy
1,373,360
+104,701
+8% +$322K ﹤0.01% 1907
2017
Q3
$4.3M Sell
1,268,659
-358,416
-22% -$997K ﹤0.01% 1887
2017
Q2
$4.02M Sell
1,627,075
-315,000
-16% -$725K ﹤0.01% 1919
2017
Q1
$4.41M Sell
1,942,075
-448,430
-19% -$992K ﹤0.01% 1906
2016
Q4
$5.07M Buy
2,390,505
+264,517
+12% +$738K ﹤0.01% 1859
2016
Q3
$6.8M Buy
2,125,988
+302,500
+17% +$960K ﹤0.01% 1802
2016
Q2
$5.73M Buy
1,823,488
+735,442
+68% +$2.45M ﹤0.01% 1839
2016
Q1
$3.62M Buy
1,088,046
+137,000
+14% +$427K ﹤0.01% 1915
2015
Q4
$3.37M Sell
951,046
-494,074
-34% -$2.07M ﹤0.01% 1949
2015
Q3
$7.27M Buy
1,445,120
+149,403
+12% +$856K ﹤0.01% 1728
2015
Q2
$8.33M Hold
1,295,717
﹤0.01% 1723
2015
Q1
$9.12M Sell
1,295,717
-115,413
-8% -$836K ﹤0.01% 1685
2014
Q4
$10.9M Sell
1,411,130
-303,264
-18% -$2.4M 0.01% 1597
2014
Q3
$12.8M Sell
1,714,394
-1,714,394
-50% -$15.9M 0.01% 1432
2014
Q2
$33.2M Buy
3,428,788
+2,359,352
+221% +$21M 0.01% 1282
2014
Q1
$8.89M Hold
1,069,436
0.01% 1639
2013
Q4
$9.03M Hold
1,069,436
0.01% 1630
2013
Q3
$8.52M Buy
1,069,436
+375,736
+54% +$3.02M 0.01% 1648
2013
Q2
$5.36M Buy
+693,700
New +$5.41M ﹤0.01% 1810

Other funds holding PDLI